热门资讯> 正文

Apogee Therapeutics报告第二季度业绩

2026-08-10 19:13

Apogee Therapeutics(APGE) 0
艾伯维公司(ABBV) 0

Apogee Therapeutics press release (APGE): Q2 net loss was $85.9 million.
AbbVie to acquire Apogee for $135.11 per share in cash for total equity value of approximately $10.9 billion, positioning differentiated immunology portfolio to reach more patients worldwide

More on Apogee Therapeutics

Apogee: 'Hold' On AbbVie $10.9B Buyout And Extended Half-Life IL-13 Zumilokibart For AD
AbbVie: Why The Pharma Wins Twice With Its Apogee Acquisition
Apogee Therapeutics, Inc. (APGE) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript
Apogee jumps 52% on $10.9B AbbVie buyout deal
Apogee soars on AbbVie deal report; analysts bullish

推荐文章

风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。